Benzinga | Jul 28, 2020 07:19AM EDT

NeoGenomics Q2 EPS $(0.04) Beats $(0.10) Estimate, Sales $86.98M Beat $86.12M Estimate

NeoGenomics (NASDAQ:NEO) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.10) by 60 percent. This is a 157.14 percent decrease over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $86.98 million which beat the analyst consensus estimate of $86.12 million by 1.00 percent. This is a 14.49 percent decrease over sales of $101.71 million the same period last year.